International Dexeus Forum - 44th edition
REPRODUCTION > CANCER
“The value of AMH in assessing ovarian function and damage in women with cancer”
Richard Anderson, MRC Centre for Reproductive Health, University of Edinburgh (UK)
Is AMH a useful marker to indicate degree of ovarian protection, for example with GnRH analogues? Current status of prediction of postchemotherapy ovarian function vs failure has been studied, with implications for post-chemotherapy endocrine treatment and for future fertility.